BIEL OTC
Bioelectronics Corporation
1W: +0.0%
1M: +0.0%
3M: +20.0%
YTD: -25.0%
1Y: +100.0%
3Y: -25.0%
5Y: -84.2%
$0.00
+0.00 (+0.00%)
Weekly Expected Move ±50.0%
$-0
$0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$496K
-30.6% ▼
5Y CAGR: -12.0%
Gross Profit
$364K
-22.0% ▼
5Y CAGR: -7.2%
Operating Income
-$393K
-43.2% ▼
Net Income
-$931K
-28.8% ▼
EPS (Diluted)
$0.00
+0.0% ▲
EBITDA
-$393K
-43.2% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| Revenue | $830K | $2M | $707K | $715K | $496K |
| YoY Growth | -11.9% | +94.0% | -56.0% | +1.0% | -30.6% |
| Cost of Revenue | $323K | $814K | $221K | $248K | $132K |
| Gross Profit | $506K | $796K | $487K | $466K | $364K |
| Gross Margin | 61.0% | 49.4% | 68.8% | 65.3% | 73.3% |
| R&D Expenses | $484K | $328K | $233K | $272K | $267K |
| SG&A Expenses | $1M | $622K | $597K | $468K | $490K |
| Operating Expenses | $2M | $950K | $830K | $741K | $756K |
| Operating Income | -$1M | -$154K | -$343K | -$274K | -$393K |
| Operating Margin | -126.3% | -9.6% | -48.6% | -38.4% | -79.2% |
| Interest Expense | $264K | $315K | $441K | $449K | $538K |
| Income Before Tax | -$1M | -$290K | -$785K | -$723K | -$931K |
| Tax Expense | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$1M | -$290K | -$785K | -$723K | -$931K |
| Net Margin | -139.8% | -18.0% | -111.0% | -101.1% | -187.6% |
| EPS (Diluted) | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| EBITDA | -$1M | $162K | -$343K | -$274K | -$393K |
| Shares Outstanding | 23.53B | 24.26B | 24.54B | 24.71B | 24.71B |